Faculty profile

Anand Krishnan

ResearcherUniversity of Saskatchewan

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Saskatchewan directory, so their courses may be missing. Find their university profile.

Anand Krishnan

Researcher

Health Sciences

University of Saskatchewan

Saskatoon, Saskatchewan, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
12 publications in the last five years, latest in 2026.
Senior (last) author on 5 recent papers, a sign of leading a research group.
Principal investigator on 3 research grants (2 NSERC, 1 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Breast Cancer Chemotherapy And Radiotherapy Decreasing Secondary Effects Of Treatment

Latest papers

Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.
Signal transduction and targeted therapy · 2026
A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer.
Oncogene · 2025
Defining the cellular and molecular features of nerve-invaded cancer cells using a newly characterized experimental model.
Cell death discovery · 2025 · senior author

All 18 publications

Latest funding

Novel non-invasive therapy to drive robust and sustained peripheral nerve regeneration
CIHR · 2022 · Co-investigator
$944,776
Potential therapies for cisplatin-induced peripheral neuropathy in breast cancer
CIHR · 2022 · Nominated PI
$60,000
Differential ontogeny contributes to the macrophage diversity in the peripheral nervous system
NSERC · 2020 · Principal investigator
$12,500

All 4 grants and awards

18 publications.

Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.

Price JDW, Vizeacoumar FS, Abuhussein O, Maranda V, Zhang Y, Adachi H, Nguyen K, Kyrylenko L, Rangel-Pozzo A, Dong H, Gong L, Materi A, Walke P, Ganapathysamy A, Denomy C, Freywald T, Dahiya R, Elhasasna H, Saxena A, Vizeacoumar JP, Patel H, Rajamanickam K, de Oliveira DM, Lazell-Wright M, Morales AM, Aggarwal A, Xu JL, Alli N, Munhoz EP, Gao P, Salsman J, Dahiya DK, Kola NS, Gonzalez-Lopez C, Thibault P, Levin M, Dellaire G, Jette N, Groot G, Köbel M, Lee CH, Hopkins L, Krishnan A, Ahmed S, Eskiw C, Barakat KH, Thakur A, Wu Y, DePinho RA, Mai S, Yu YT, Wong JMY, Freywald A, Vizeacoumar FJ

Signal transduction and targeted therapy2026

DOI: 10.1038/s41392-026-02750-0 PMID: 42236690

A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer.

Walke P, Price JDW, Vizeacoumar FS, Joseph N, Maranda V, Chowdhury B, Patel J, Zhang Y, Dong H, New L, Ganapathysamy A, Gong LH, Lazell-Wright M, Elhasasna H, Bhanumathy KK, Wu Y, Wang Y, Freywald A, Krishnan A, Vizeacoumar FJ

Oncogene2025

DOI: 10.1038/s41388-025-03413-0 PMID: 40301542

Defining the cellular and molecular features of nerve-invaded cancer cells using a newly characterized experimental model.

Joseph N, Shrestha S, Sassmannshausen I, Mitzkus S, Chumala P, Sivakumar B, Baiju V, Ahmed S, Rees H, Katselis GS, Krishnan A

Cell death discovery2025Senior author

DOI: 10.1038/s41420-025-02616-4 PMID: 40628700

Schwann cells modified to secrete MANF is a potential cellular therapy for peripheral nerve regeneration.

Sivakumar B, Hammond C, Martinez V, Joseph N, John JV, Kumar A, Krishnan A

Cell regeneration (London, England)2025Senior author

DOI: 10.1186/s13619-025-00247-9 PMID: 40622554

Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality.

Cunningham CE, Vizeacoumar FS, Zhang Y, Kyrylenko L, Both S, Maranda V, Dong H, Price JDW, Gao P, Wagner K, Wu Y, Lazell-Wright M, Ganapathysamy A, Hari R, Bhanumathy KK, Denomy C, Saxena A, Vizeacoumar JP, Morales AM, Khan F, Mosley S, Chen A, Katrii T, Zoller BGE, Rajamanickam K, Walke P, Gong L, Patel H, Elhasasna H, Dahiya R, Abuhussein O, Dmitriev A, Freywald T, Munhoz EP, Ruppin E, Lee JS, Rox K, Koebel M, Hopkins L, Lee CH, Yadav S, Gasparoni G, Walter J, Krishnan A, Datla R, Toosi B, Baker K, Meens J, Cescon DW, Ailles L, Leary SC, Wu Y, Empting M, Kiemer AK, Freywald A, Vizeacoumar FJ

Cell genomics2025

DOI: 10.1016/j.xgen.2025.100876 PMID: 40347943

Manipulation of the Myc Interactome to Enhance Nerve Regeneration in a Murine Model.

Poitras TM, Komirishetty P, Areti A, Larouche M, Krishnan A, Chandrasekhar A, Munchrath E, Zochodne DW

Annals of neurology2024

DOI: 10.1002/ana.26950 PMID: 38818756

Hallmarks of peripheral nerve injury and regeneration.

Krishnan A, Verge VMK, Zochodne DW

Handbook of clinical neurology2024First author

DOI: 10.1016/b978-0-323-90108-6.00014-4 PMID: 38697733

Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF): An Emerging Therapeutic Target for Neurodegenerative Disorders.

Sivakumar B, Krishnan A

Cells2023Senior author

DOI: 10.3390/cells12071032 PMID: 37048105

Comparative Proteomics Analysis of Growth-Primed Adult Dorsal Root Ganglia Reveals Key Molecular Mediators for Peripheral Nerve Regeneration.

Bautista M, Katselis GS, Chowdhury B, Chumala P, Mahendra R, Desai P, Hall J, Kalyaanamoorthy S, Krishnan A

eNeuro2023Senior author

DOI: 10.1523/eneuro.0168-22.2022 PMID: 36526365

Survival of compromised adult sensory neurons involves macrovesicular formation.

Krishnan A, Areti A, Komirishetty P, Chandrasekhar A, Cheng C, Zochodne DW

Cell death discovery2022First author

DOI: 10.1038/s41420-022-01247-3 PMID: 36424403

Something wrong or missing on this profile? Suggest a correction

Anand Krishnan

Research

Latest papers

Latest funding

Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.

A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer.

Defining the cellular and molecular features of nerve-invaded cancer cells using a newly characterized experimental model.

Schwann cells modified to secrete MANF is a potential cellular therapy for peripheral nerve regeneration.

Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality.

Manipulation of the Myc Interactome to Enhance Nerve Regeneration in a Murine Model.

Hallmarks of peripheral nerve injury and regeneration.

Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF): An Emerging Therapeutic Target for Neurodegenerative Disorders.

Comparative Proteomics Analysis of Growth-Primed Adult Dorsal Root Ganglia Reveals Key Molecular Mediators for Peripheral Nerve Regeneration.

Survival of compromised adult sensory neurons involves macrovesicular formation.

Novel non-invasive therapy to drive robust and sustained peripheral nerve regeneration

Potential therapies for cisplatin-induced peripheral neuropathy in breast cancer

Differential ontogeny contributes to the macrophage diversity in the peripheral nervous system

Differential ontogeny contributes to the macrophage diversity in the peripheral nervous system

Frequent collaborators

Andrew Freywald

Shahid Ahmed

Aneesh Thakur

Laurie Ailles

Graham Dellaire

Kristi Baker

Christopher Eskiw

Yuzhuo Wang

Gary Groot

Sabine Mai